Søgeresultater - Susan O’Brien

Refine Results
  1. 1
    Initial treatment of CLL: integrating biology and functional status

    Initial treatment of CLL: integrating biology and functional status af Nitin Jain, Susan O’Brien

    Udgivet 2015
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  2. 2
    Reply to myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: Analysis of persistent and new‐onset cytopenia

    Reply to myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: Analysis of persistent and new‐onset cytopenia... af Paolo Strati, Susan O’Brien

    Udgivet 2013
    Få fuldtekst Få fuldtekst
    Carta
    Føj til favoritter
    Saved in:
  3. 3
    Immune defects in patients with chronic lymphocytic leukemia

    Immune defects in patients with chronic lymphocytic leukemia af Farhad Ravandi, Susan O’Brien

    Udgivet 2005
    Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  4. 4
    Update on Therapy of Chronic Lymphocytic Leukemia

    Update on Therapy of Chronic Lymphocytic Leukemia af John G. Gribben, Susan O’Brien

    Udgivet 2011
    Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  5. 5
    Chronic Lymphocytic Leukemia: Diagnosis and Treatment

    Chronic Lymphocytic Leukemia: Diagnosis and Treatment af Paolo Strati, Nitin Jain, Susan O’Brien

    Udgivet 2018
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  6. 6
    Treatment of chronic myelogenous leukemia: current status and investigational options [see comments]

    Treatment of chronic myelogenous leukemia: current status and investigational options [see comments] af HM Kantarjian, Susan O’Brien, Paolo Anderlini, Moshe Talpaz

    Udgivet 1996
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  7. 7
    Discontinuation of imatinib therapy after achieving a molecular response

    Discontinuation of imatinib therapy after achieving a molecular response af Jorge E. Cortés, Susan O’Brien, Hagop M. Kantarjian

    Udgivet 2004
    Få fuldtekst Få fuldtekst
    Carta
    Føj til favoritter
    Saved in:
  8. 8
    Homoharringtonine/Omacetaxine Mepesuccinate: The Long and Winding Road to Food and Drug Administration Approval

    Homoharringtonine/Omacetaxine Mepesuccinate: The Long and Winding Road to Food and Drug Administration Approval af Hagop M. Kantarjian, Susan O’Brien, Jorge E. Cortés

    Udgivet 2013
    Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  9. 9
    Advances in the biology and treatment of B-cell chronic lymphocytic leukemia

    Advances in the biology and treatment of B-cell chronic lymphocytic leukemia af Susan O’Brien, Auro del Giglio, Michael J. Keating

    Udgivet 1995
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  10. 10
    Acute lymphoblastic leukemia in adolescents and young adults

    Acute lymphoblastic leukemia in adolescents and young adults af Michael Rytting, Elias Jabbour, Susan O’Brien, Hagop M. Kantarjian

    Udgivet 2017
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  11. 11
    Monoclonal antibodies in acute lymphoblastic leukemia

    Monoclonal antibodies in acute lymphoblastic leukemia af Elias Jabbour, Susan O’Brien, Farhad Ravandi, Hagop M. Kantarjian

    Udgivet 2015
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  12. 12
    New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia

    New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia af Elias Jabbour, Susan O’Brien, Marina Konopleva, Hagop M. Kantarjian

    Udgivet 2015
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  13. 13
    Monoclonal Antibody-Based Therapies: A New Dawn in the Treatment of Acute Lymphoblastic Leukemia

    Monoclonal Antibody-Based Therapies: A New Dawn in the Treatment of Acute Lymphoblastic Leukemia af Hagop M. Kantarjian, Deborah A. Thomas, Alan S. Wayne, Susan O’Brien

    Udgivet 2012
    Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  14. 14
    Recent advances in de novo CD5<sup>+</sup> diffuse large B cell lymphoma

    Recent advances in de novo CD5<sup>+</sup> diffuse large B cell lymphoma af Preetesh Jain, Luis Fayad, Andreas Rosenwald, Ken H. Young, Susan O’Brien

    Udgivet 2013
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  15. 15
    Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis

    Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis af Amit Bar‐Or, Susan O’Brien, Michael Sweeney, Edward Fox, Jeffrey A. Cohen

    Udgivet 2021
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  16. 16
    Initial experience with CMC-544 (inotuzumab ozogamicin) in pediatric patients with relapsed B-cell acute lymphoblastic leukemia

    Initial experience with CMC-544 (inotuzumab ozogamicin) in pediatric patients with relapsed B-cell acute lymphoblastic leukemia af Michael Rytting, Lisa Triche, Deborah A. Thomas, Susan O’Brien, Hagop M. Kantarjian

    Udgivet 2013
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  17. 17
    Imatinib mesylate causes hypopigmentation in the skin

    Imatinib mesylate causes hypopigmentation in the skin af Anne S. Tsao, Hagop M. Kantarjian, Jorge E. Cortés, Susan O’Brien, Moshe Talpaz

    Udgivet 2003
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  18. 18
    Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia

    Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine... af Kensuke Kojima, Marina Konopleva, Teresa McQueen, Susan O’Brien, William Plunkett, Michael Andreeff

    Udgivet 2006
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  19. 19
    Philadelphia-Positive Acute Lymphoblastic Leukemia: Current Treatment Options

    Philadelphia-Positive Acute Lymphoblastic Leukemia: Current Treatment Options af Theresa Liu-Dumlao, Hagop M. Kantarjian, Deborah A. Thomas, Susan O’Brien, Farhad Ravandi

    Udgivet 2012
    Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  20. 20
    Current and emerging treatment options in chronic myeloid leukemia

    Current and emerging treatment options in chronic myeloid leukemia af Elias Jabbour, Jorge E. Cortés, Francis J. Giles, Susan O’Brien, Hagop M. Kantarjian

    Udgivet 2007
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:

Søgeredskaber: